Arch Biopartners
Arch Biopartners is a biotechnology firm that focuses on the treatment of respiratory Pseudomonas aeruginosin infections.
Business Model:
Revenue: $37.6k
Employees: 11-50
Rankings
Industries / Tags:
Detailed Arch Biopartners Information
Geographic Data
Address: 545 King Street West
City: Toronto
State: ontario
Zip: M5V 1M1
Country: CA
Financial Info
Stage:
grant
Raised Last:
$750k
Raised Total:$1M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Arch Biopartners is a biotechnology firm that focuses on the treatment of respiratory Pseudomonas aeruginosin infections.
Contact Phone:
Contact Email:
Arch Biopartners went public on 12/31/2010 on the NYSE
Listed Exchange:
NYSE
IPO Date:
12/31/2010
Ticker Symbol:
ACH
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2020 | Private Placement | $500k | 2/2020 | Convertible Note | $376.3k | 3/2018 | Private Placement | $1.3M | 1/2015 | Post-IPO Equity | $265k | 6/2020 | Private Placement | $1M | 5/2019 | Debt | $745.7k | 7/2021 | Grant | 1 | $750k |
Canadian Institutes of Health Research Canadian Institutes of Health Research |
8/2014 | Post-IPO Equity | $155.5k |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
